Richard Croarkin - Jun 9, 2022 Form 4 Insider Report for AERIE PHARMACEUTICALS INC (AERI)

Role
Director
Signature
/s/ John W. LaRocca, Attorney-in-Fact for Richard Croarkin
Stock symbol
AERI
Transactions as of
Jun 9, 2022
Transactions value $
$0
Form type
4
Date filed
6/13/2022, 04:43 PM
Previous filing
Jun 21, 2021
Next filing
Jun 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AERI Common Stock Award $0 +6.25K +63.4% $0.00 16.1K Jun 9, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AERI Stock Option (right to buy) Award $0 +16.9K $0.00 16.9K Jun 9, 2022 Common Stock 16.9K $6.11 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the reporting person's continued service on the board of directors of the issuer through the vesting date, these shares of Common Stock are scheduled to vest on June 9, 2023.
F2 Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is scheduled to vest ratably on each of the first 12 monthly anniversaries of June 9, 2022.